Turkey Report: CPhI and GBR unveals the Turkish pharma market as never before

GET THE REPORT

FILL IN THE FORM BELOW AND GET NOW YOUR FREE COPY OF “TURKEY PHARMACEUTICALS MANUFACTURING”

I have read, understood and consent to your Privacy Policy.

?

Mix with the world of Pharma products, people & solutions

About CPhI:

CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, Korea, China, India, Japan, Southeast Asia, Istanbul, Russia and North America and co-locates with ICSE for contract services, P-MEC for machinery, equipment & technology, InnoPack for pharmaceutical packaging, BioPh for biopharma and FDF for finished dosage formulation. CPhI provides an online buyer & supplier directory at CPhI-Online.com.

For more information visit: www.cphi.com

About UBM EMEA:

UBM EMEA connects people and creates opportunities for companies across five continents to develop new business, meet customers, launch new products, promote their brands, and expand their market. Through premier brands such as TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete Show, and many others, UBM EMEA exhibitions, conferences, awards programs, publications, Websites, and training and certification programs are an integral part of the marketing plans of companies across more than 20 industry sectors.

About UBM plc:

UBM plc is a global events-led marketing services and communications company.  We help businesses do business, bringing the world’s buyers and sellers together at events and online, as well as producing and distributing news and specialist content.  Our 5,000 staff in more than 30 countries are organised into expert teams which serve commercial and professional communities, helping them to do business and their markets to work effectively and efficiently.

For more information visit: www.ubm.com

Follow us on Twitter at @UBM_plc to get the latest UBM corporate news; follow @UBM for news and updates from across the businesses and selected members of UBMs Twitter.

About GBR:

Headquartered in Singapore and with offices in Istanbul, Global Business Reports (GBR) was established in 2001 in order to provide up to date and first-hand information for global business decision makers. In an age where cross boundary trade and investment and the globalization process are the driving factors for businesses, information is crucial. Precise sectorial reports help companies understand and expand their markets, improve their sourcing chain, target their investments and discover the trends affecting their industry around the world. GBR provides in depth surveys and up to date information and data covering all aspects of the Hydrocarbon, Pharmaceuticals, Chemical, Energy, Minerals, Mining and the Metallurgical industries around the world.

Download now the full version of this report which gives a deep insight into the current state of the Turkish pharmaceutical industry – estimated value of USD 2,000, is brought to you as a gift from CPhI Pharma Portfolio, UBM plc.

Report Highlights:

  • Turkish market consists of 300 pharma companies, producing over 8000 drugs and employing 30000 people with a $7Bn turnover
  • Turkish manufacturers are investing heavily in new facilities
  • IP protection in country seen as under rated strength with many generics manufacturers now patenting their own processes
  • Turkey a key destination for foreign investment
  • Local manufacturers need to diversify product portfolios in order to prevent takeovers
  • R&D and domestic manufacturing innovation is vital for industry’s development
  • Export led growth throughout MENA/East Europe seen as major driver of sales
  • Overall growth forecast at 6% per annum
  • Turkeys largest exporters seeing a double digit sales growth
CPhI: TURKEY PHARMACEUTICALS MANUFACTURING report

Copyright © 2016 UBM

Please correct the following errors: